Journal of Mental Health and Substance Research Psychedelic Pharmacology in Psychiatry: The Mechanisms and Therapeutic Potential of Psilocybin, MDMA, and LSD in Mental Health Disorders This review examines the mechanisms and therapeutic potential of psilocybin, MDMA, and LSD for depression, PTSD, and anxiety disorders.
BMC Medical Education Further Education in Psychedelic-Assisted Therapy – Experiences from Switzerland Examining Switzerland’s training framework for psychedelic-assisted therapy and its role in ensuring safe and effective clinical implementation.
ACS Pharmacology & Translational Science Psychedelics and Eating Disorders: Exploring the Therapeutic Potential for Anorexia Nervosa and Beyond A review of the therapeutic potential of psychedelics for anorexia nervosa, highlighting neurobiological and psychological mechanisms.
PSM Biological Research The Role of Psychedelics in Treating Mental Health Disorders: A Mini-Review A review of historical and contemporary research on psychedelics in treating depression, PTSD, and anxiety, highlighting their therapeutic potential.
The Permanente Journal A Review of the Federal Drug Administration Pipeline and Proposed California Legislation on Medicinal Psychedelics A review of FDA psychedelic trials and California’s legislative efforts to expand access, balancing safety, efficacy, and regulatory concerns.
Australian & New Zealand Journal of Psychiatry Safety and Efficacy of Methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy in Post-Traumatic Stress Disorder: An Overview of Systematic Reviews and Meta-Analyses A review of systematic analyses on MDMA-assisted psychotherapy for PTSD, highlighting efficacy, safety concerns, and future research needs.
Journal of Clinical Medicine Psychedelics and Suicide-Related Outcomes: A Systematic Review A systematic review evaluating the effects of psychedelics on suicide-related outcomes, highlighting potential benefits and risks of psilocybin, MDMA, and LSD.
Journal of Substance Abuse Treatment Preparations for Rave Music Parties and Consequences for Attendees Who Consume Psychedelic Drugs A study on psychedelic use at rave parties, examining pre-party preparations, post-party effects, and policy implications for harm reduction.
General Psychiatry Expanded Access to Psychedelic Treatments: Comparing American and Canadian Policies A policy analysis comparing Canada’s Special Access Program and the U.S. FDA’s Expanded Access Program for psychedelic-assisted therapy.
bioRxiv Dissociable Effects of LSD and MDMA on Striato-Cortical Connectivity in Healthy Subjects A study finds LSD enhances sensory-cognitive connectivity, while MDMA reduces amygdala-limbic connectivity, with implications for therapy.
University of Lethbridge Canadian Psychologists’ and Psychology Graduate Students’ Perceptions of Psychedelic Therapy A study examining Canadian psychologists’ and psychology graduate students’ perceptions of psychedelic therapy, highlighting knowledge gaps and training needs.
The American Journal of Psychiatry MDMA and MDMA-Assisted Therapy MDMA-assisted therapy shows promising results in PTSD treatment, but FDA concerns require further trials before approval.
Psilocybin Into the Wild Frontier: Mapping the Terrain of Adverse Events in Psychedelic-Assisted Therapies This study aims to explore the risks associated with psychedelic-assisted therapies (PATs) by evaluating potential adverse events (AEs) to develop a comprehensive and standardized assessment framework.
Journal of Psychedelic Studies Experiences of Psychedelic Drug Use Among People with Psychotic Symptoms and Disorders: Personal Growth and Mystical Experiences A study reveals potential benefits and risks of psychedelics for individuals with psychotic disorders, emphasizing personal growth and mystical experiences.
Journal of Psychedelic Studies Critical Review of 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy for Posttraumatic Stress Disorder: Unanswered Questions and Future Directions This study critically reviews randomized controlled trials (RCTs) of MDMA-assisted therapy (MDMA-AT) for PTSD, focusing on efficacy, methodological issues, and future research directions.
